Literature DB >> 8910332

The minimum functional unit of human P-glycoprotein appears to be a monomer.

T W Loo1, D M Clarke.   

Abstract

Several studies have demonstrated the presence of oligomers of P-glycoprotein in multidrug-resistant cells. The minimum functional unit of P-glycoprotein, however, is not known. In order to determine whether the functional unit is an oligomer, we tested for associations between P-glycoproteins containing either a histidine tag or the epitope tag for monoclonal antibody A52 at the COOH-terminal end of the molecule. Both tagged molecules were active and had indistinguishable drug resistance profiles. The tagged P-glycoproteins were expressed contemporaneously in HEK 293 cells, purified by nickel-chelate chromatography followed by immunoblot analysis. We found that P-glycoprotein-A52 did not copurify with functionally active P-glycoprotein-(His)10, even when the former was overexpressed relative to the histidine-tagged protein. Similar results were obtained with phosphorylation-deficient mutants of P-glycoprotein. By contrast, we could purify and reconstitute drug-stimulated ATPase activity when the half-molecules NH2-terminal half-(His)10/COOH-terminal half-A52 or NH2-terminal half-A52/COOH-terminal half-(His)10 were coexpressed in HEK 293 cells. These results suggest that nickel-chelate chromatography may be a suitable method for studying protein-protein interactions in membrane proteins and that the minimal functional unit of P-glycoprotein is likely to be a monomer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910332     DOI: 10.1074/jbc.271.44.27488

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study.

Authors:  Robert M Rutledge; Lothar Esser; Jichun Ma; Di Xia
Journal:  J Struct Biol       Date:  2010-10-27       Impact factor: 2.867

Review 2.  Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say!

Authors:  H T Idriss; Y A Hannun; E Boulpaep; S Basavappa
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

3.  P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; William D Staatz; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristen Demarco; Mei-Li Laracuente; Patrick T Ronaldson; Thomas P Davis
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

Review 4.  Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.

Authors:  F S Seibert; T W Loo; D M Clarke; J R Riordan
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

Review 5.  Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.

Authors:  T W Loo; D M Clarke
Journal:  J Membr Biol       Date:  2005-08       Impact factor: 1.843

6.  Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site.

Authors:  Tip W Loo; David M Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

7.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

8.  Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

Review 9.  Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.

Authors:  Chung-Jung Tsai; Zuben E Sauna; Chava Kimchi-Sarfaty; Suresh V Ambudkar; Michael M Gottesman; Ruth Nussinov
Journal:  J Mol Biol       Date:  2008-08-12       Impact factor: 5.469

10.  Molecular analysis of the multidrug transporter, P-glycoprotein.

Authors:  U A Germann; T C Chambers
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.